Expert Information

Not since 2003 has a new medication been approved by the FDA for treatment of Alzheimer’s disease (AD). Fortunately, this long dry spell may be nearing an end. This article explores a variety of clinical trials that may one day provide new treatments and methods to more effectively manage Alzheimer’s disease.

Learn helpful information to manage glaucoma during the COVID-19 pandemic, including when to contact your eye doctor, and what to expect if you visit the doctor’s office or hospital.

Normal pressure hydrocephalus (NPH) is a disorder characterized by 3 symptoms: dementia, gait disorder, and incontinence. Learn about diagnosis & treatment.

Important information about COVID-19 risk factors for the elderly and protecting Alzheimer’s and dementia patients during the current coronavirus pandemic.

Learn about Stargardt disease and Best's disease, two forms of macular degeneration that affect children and young adults.

Iridocorneal endothelial syndrome, or ICE syndrome, is a group of eye diseases that can lead to glaucoma.

Since age-related macular degeneration (AMD) is a leading cause of vision loss in Americans 60 years of age and older, it’s important to take steps that may prevent this eye disease. Certain measures have been shown in large clinical trials to clearly decrease the risk of AMD, and other actions, based on smaller trials or theoretical considerations, may also decrease risk.

Many people with visual impairment can benefit from apps, helpful websites, and specific computer settings.

Learn about low-vision evaluation, occupational therapists who specialize in helping people with low vision, and how to find helpful organizations.

Weight, which includes obesity, is linked with Alzheimer’s disease. This is an area of very active investigation as researchers discover associations between brain health and the body chemistry that controls weight.